Hong Kong stocks surged | Hengrui Medicine (01276.HK) up by over 5% again, received the "Notice of Approval for Drug Clinical Trial" issued by the National Medical Products Administration for HRS-7172 tablets.

According to the Wisdom Financial APP, Hengrui Medicine (01276.HK) surged over 5% again, with an increase of 5.47% as of the time of publication, reaching 84.9 Hong Kong dollars, with a trading volume of 153 million Hong Kong dollars.